| Open |
S1922 |
Randomized Phase II Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma |
12/16/2019 |
|
78% |
|
|
| Open |
S2107 |
Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable… |
6/6/2022 |
|
100% |
|
|
| Closed |
S1106 |
Randomized Phase II Younger Patients Mantle Cell Lymphoma |
10/1/2011 |
6/26/2013 |
29% |
|
Published
|
| Open |
S1800E |
Randomized Phase II/III Study of Cemi plus Doce and Ram vs SOC in Previously Treated/Recurrent |
4/28/2025 |
|
2% |
|
|
| Closed |
SWOG-8795 (INT-0094) (EST-1888) |
Randomized Prospective Comparison of Bacillus Calmette-Guerin and Mitomycin-C Therapy and Prophylaxis in Superficial Transitional Cell Carcinoma of the Bladder with DNA Flow Cytometric Analysis |
12/1/1988 |
5/15/1992 |
65% |
|
Published
|
| Closed |
SWOG-9115 (EST-1192) (INT-0127) |
Randomized Study of Standard Chemotherapy vs. STAMP V with Autologous Stem Cell Infusion in Stage IV Poor Prognosis Breast Carcinoma, Phase III, a BMT Study (Intergroup) |
2/1/1992 |
1/1/1994 |
14% |
|
|
| Closed |
SWOG-9308 |
Randomized Trial Comparing Cisplatin With Cisplatin Plus Intravenous Navelbine® in the Treatment of Previously Untreated, Stage IV Non-Small Cell Lung Cancer Patients |
10/15/1993 |
6/1/1995 |
98% |
|
Published
|
| Closed |
SWOG-9035 |
Randomized Trial of Adjuvant Immunotherapy with an Allogeneic Melanoma Vaccine for Patients with Intermediate Thickness, Node Negative Malignant Melanoma (T3N0M0), Phase III. |
4/15/1992 |
11/15/1996 |
100% |
|
Published
|
| Closed |
S1200 |
Randomized trial with acupuncture for joint symptoms related to AIs in women with early stg brst ca |
3/27/2012 |
|
99% |
|
|
| Closed |
S1406 |
Rano Ph II of Irino+Cetuximab +/- Vemurafenib in BRAF mutant mCRC |
11/13/2014 |
4/1/2016 |
100% |
|
|
| Closed |
S0000C |
RAS |
6/4/2004 |
5/1/2007 |
94% |
|
Published
|
| Closed |
SWOG-8515 |
Reactivated (unfavorable histology only): 4/15/90, Temporarily Closed (unfavorable histology only): 11/1/89 Evaluation of Menogaril (NSC-269148) in Non-Hodgkin's Lymphoma |
3/15/1988 |
12/15/1991 |
97% |
|
Published
|
| Closed |
SWOG-9318 |
Recombinant Human Erythropoietin (r-HuEPO) as an Adjunct to Radiation Therapy and Cisplatin for Patients with Stages II-B, III and IV-A Carcinoma of the Cervix, Phase II |
12/15/1994 |
3/1/1999 |
98% |
|
Published
|
| Closed |
SWOG-8642 |
Recombinant Human Interferon-Gamma for the Adjuvant Treatment of High Risk Malignant Melanoma After Surgical Excision of the Primary Lesion |
6/1/1987 |
5/15/1990 |
100% |
|
Published
|
| Closed |
SWOG-9304 (INT-0144) |
RECTAL |
3/1/1994 |
8/1/2000 |
98% |
|
Published
|
| Closed |
S0304 |
RECTAL |
8/1/2004 |
2/1/2006 |
0% |
|
|
| Closed |
S0329 |
Recurrent of Metastatic Squamous Cell Carcinoma of the Head and Neck |
1/1/2005 |
1/1/2007 |
100% |
|
Published
|
| Closed |
S0420 |
Recurrent or Metastatic Head and Neck Cancer |
10/1/2004 |
|
100% |
|
Published
|
| Closed |
S0618 |
Recurrent or Metastatic Squamous Cell |
5/1/2006 |
1/1/2008 |
95% |
|
Published
|
| Closed |
S9902 |
Recurrent, Refractory or Metastatic |
11/15/1999 |
1/1/2001 |
97% |
|
Published
|
